Comparative effectiveness of glycemic control in patients with type 2 diabetes treated with GLP-1 receptor agonists: a network meta-analysis of placebo-controlled and active-comparator trials

BACKGROUND: Clinical studies of patients with type 2 diabetes show that GLP-1 receptor agonists (GLP-1 RAs) improve glycemic control and promote weight loss. We conducted a Bayesian network meta-analysis (NMA) of placebo- and active-controlled randomized trials to assess the comparative effectivenes...

Descripción completa

Detalles Bibliográficos
Autores principales: Orme, Michelle E, Nguyen, Hiep, Lu, Jackie Y, Thomas, Susan A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386609/
https://www.ncbi.nlm.nih.gov/pubmed/28435304
http://dx.doi.org/10.2147/DMSO.S116810

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386609/
https://www.ncbi.nlm.nih.gov/pubmed/28435304
http://dx.doi.org/10.2147/DMSO.S116810

Ejemplares similares